NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD

INTRODUCTION: Serum phosphate levels are insufficiently controlled in many patients with end-stage renal disease (ESRD), and novel therapeutic strategies are needed. Blocking intestinal phosphate absorption mediated by sodium-dependent phosphate co-transporter type 2b (NPT-IIb) holds promise; thus,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Larsson, Tobias E., Kameoka, Chisato, Nakajo, Ikumi, Taniuchi, Yuta, Yoshida, Satoshi, Akizawa, Tadao, Smulders, Ronald A.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762974/
https://ncbi.nlm.nih.gov/pubmed/29340316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2017.08.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados